for the Clinical Pharmacy Cardiac Risk Service Study Group
Articles by for the Clinical Pharmacy Cardiac Risk Service Study Group

Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management
ByKari L. Olson, PharmD,Thomas Delate, PhD,Jon Rasmussen, PharmD,Tammy L. Humphries, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.

Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
ByKaren J. McConnell, PharmD,Emily B. Zadvorny, PharmD,Anne M. Denham, PharmD,Sheila L. Kasten, PharmD,Kara A. Hutka, PharmD,Cedar R. Koetting, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group